Pascale Burtin

Title: Pascale Burtin: Innovator in S1P Receptor Modulation

Introduction

Pascale Burtin is a notable inventor based in Huningue, France. She has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis and other inflammatory disorders. With a total of 2 patents, her work focuses on innovative dosage regimens for S1P receptor modulators.

Latest Patents

Pascale Burtin's latest patents include a dosage regimen of an S1P receptor modulator aimed at treating patients suffering from multiple sclerosis. This invention emphasizes the importance of testing patients for a history of infection caused by the varicella zoster virus and ensuring they are vaccinated prior to the administration of the S1P receptor modulator or agonist. Another patent also addresses a dosage regimen for S1P receptor modulators in the treatment of inflammatory or autoimmune disorders, specifically highlighting the need for patient vaccination before administering fingolimod or its pharmaceutically acceptable salts at a daily dosage of 0.5 mg.

Career Highlights

Throughout her career, Pascale Burtin has worked with prominent companies, including Novartis AG. Her expertise in pharmacology and innovative treatment strategies has positioned her as a key figure in her field.

Collaborations

Pascale has collaborated with notable professionals such as Craig Boulton and Olivier David, contributing to advancements in her research and development efforts.

Conclusion

Pascale Burtin's innovative work in S1P receptor modulation showcases her dedication to improving treatment options for patients with multiple sclerosis and other autoimmune disorders. Her contributions to the field are significant and continue to influence medical practices today.